Skip to content

Hybrid Blood Pressure Monitor Validation

Validation of a Hybrid Blood Pressure Monitor to Replace the Mercury Standard for Validation Studies According to Modified Criteria of the European Society of Hypertension International Protocol 2010

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01120990
Acronym
NISSEI
Enrollment
51
Registered
2010-05-11
Start date
2010-04-30
Completion date
2010-07-31
Last updated
2012-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Keywords

Blood pressure measuring devices, Essential Hypertension, Automated blood pressure measurement

Brief summary

Assessment of the accuracy of a Blood Pressure Measuring Device with a digital display-column, NISSEI DM 3000, according to an adaptation of the European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults.

Detailed description

According to the European Society of Hypertension International Protocol Revision 2010 for the Validation of Blood Pressure Measuring Devices in Adults, 33 patients have their blood pressure measured by two observers using parallel connected mercury sphygmomanometers, blinded from each other's result, and then by the supervisor using the tested device, NISSEI DM 3000. The measurements using the mercury sphygmomanometers are repeated 5 times and in between them, 4 measurements using the tested device take place. If the results of the comparison of these measurements according to the analysis required by the protocol, meet the required criteria, the device is regarded as Pass, otherwise as Fail. In this study, instead of consecutive, simultaneous measurements of the two mercury sphygmomanometers and tha tested device will be taking place. This will be so to exclude any inaccuracy due to blood pressure variability and because the tested device has a controllable deflation rate and allows simultaneous measurements with the mercury sphygmomanometers. In addition, the investigators will be performing 6 set of measurements instead of 4.

Interventions

OTHERBlood Pressure Measurement

All patients have their blood pressure measured simultaneously by two observers using parallel connected mercury sphygmomanometers and by a supervisor using the tested device, NISSEI DM 3000. Six sets of measurements are performed.

Sponsors

University of Athens
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Above 25 years of age * Sinus rhythm * Informed consent

Exclusion criteria

* Sustained arrhythmia * Pregnancy * Poor quality Korotkoff sounds * Unavailable cuff size * Completed blood pressure range (according to protocol)

Design outcomes

Primary

MeasureTime frameDescription
Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.3 monthsMean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Systolic Blood Pressure Measured by Tested Device.3 monthsMean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.
Systolic Blood Pressure Measured With Mercury Sphygmomanometer.3 monthsMean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.
Diastolic Blood Pressure Measured by Tested Device.3 monthsMean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.

Countries

Greece

Participant flow

Participants by arm

ArmCount
All Patients
All patients included in the study with complete blood pressure measurements data consist a single group. The tested value is the degree of agreement between measurements performed with mercury devices and with the tested device
51
Total51

Baseline characteristics

CharacteristicAll Patients
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
16 Participants
Age, Categorical
Between 18 and 65 years
35 Participants
Age Continuous50.4 years
STANDARD_DEVIATION 16.3
Region of Enrollment
Greece
51 participants
Sex: Female, Male
Female
20 Participants
Sex: Female, Male
Male
31 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 51
serious
Total, serious adverse events
0 / 51

Outcome results

Primary

Diastolic Blood Pressure Measured by Tested Device.

Mean Diastolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.

Time frame: 3 months

Population: According to the European Society of Hypertension International Protocol 2010, recruitment is continued until 33 subjects that meet the entry criteria complete all the measurements.

ArmMeasureValue (MEAN)Dispersion
All PatientsDiastolic Blood Pressure Measured by Tested Device.90.72 mmHgStandard Deviation 20.02
Primary

Diastolic Blood Pressure Measured With Mercury Sphygmomanometer.

Mean Diastolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.

Time frame: 3 months

Population: According to the European Society of Hypertension International Protocol 2010, recruitment is continued until 33 subjects that meet the entry criteria complete all the measurements.

ArmMeasureValue (MEAN)Dispersion
All PatientsDiastolic Blood Pressure Measured With Mercury Sphygmomanometer.90.51 mmHgStandard Deviation 19.87
Primary

Systolic Blood Pressure Measured by Tested Device.

Mean Systolic Blood pressure value of all BP measurements made by the tested device in all patients included in the analysis.

Time frame: 3 months

Population: According to the European Society of Hypertension International Protocol 2010, recruitment is continued until 33 subjects that meet the entry criteria complete all the measurements.

ArmMeasureValue (MEAN)Dispersion
All PatientsSystolic Blood Pressure Measured by Tested Device.144.11 mmHgStandard Deviation 27.72
Primary

Systolic Blood Pressure Measured With Mercury Sphygmomanometer.

Mean Systolic Blood pressure value of all BP measurements made by the two observers with mercury sphygmomanometers in all patients included in the analysis.

Time frame: 3 months

Population: According to the European Society of Hypertension International Protocol 2010, recruitment is continued until 33 subjects that meet the entry criteria complete all the measurements.

ArmMeasureValue (MEAN)Dispersion
All PatientsSystolic Blood Pressure Measured With Mercury Sphygmomanometer.143.92 mmHgStandard Deviation 27.18

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026